Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Vaxzevria is Highly Effective After One Dose Against Severe Disease or Hospitalisation Caused by Beta and Delta Variants of Concern
Results from the Canadian Immunization Research Network (CIRN) with support from Public Health Agency of […]
X-Vax Technology Appoints Varsha K. Jain, MD as Chief Clinical Development Officer
X-Vax Technology, Inc. (X-VAX®), a biotechnology company developing vaccines based on a new approach that […]
Amadeus Integrates IBM Digital Health Pass Into its Digital Health Verification Technology
IBM (NYSE: IBM) and Amadeus (MCE: AMS) today announced that they are working together to […]
First Treatment Approved in England for Advanced Bile Duct Cancer
The drug pemigatinib (Pemazyre) will now be an option for people with a rare type of bile […]
Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent […]
Access to Genetic Results Allows for More Personalised Cancer Treatments
Doctors in Wales are now able to access digital genetic test results for urgent cancer […]
Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform
Coave Therapeutics (pronounced ‘cove’; formerly Horama), a clinical stage biotechnology company focused on developing life […]
19Labs, Doctory Bring Next Generation Telehealth Kiosks to the Middle East
The hospital-at-home trend is rapidly changing the healthcare industry globally and throughout the Gulf countries. […]
Cityzenith and SafelyThrive Digital Twin Tech Partnership Delivers Major Solution to 'COVID Delta' Variant
As the world reels from the threat of COVID-19’s new and highly contagious Delta variant, […]
Government Launches Covid Pass Verifier App for Businesses
Trials of the COVID Pass in domestic settings supported the beginning of a summer of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more